Blood Transfusion Policy. (St John s Hospice)
|
|
- Dwight Carroll
- 5 years ago
- Views:
Transcription
1 Blood Transfusion Policy (St John s Hospice) DOCUMENT CONTROL: Version: 3 Ratified by: Quality Assurance Sub-Committee Date ratified: 6 December 2017 Name of originator/author: Macmillan Specialist Palliative Care Nurse Name of responsible Consultant Clinical Quality Group committee/individual: Date issued: 9 March 2018 Review date: December 2020 Target Audience All staff within St John s Hospice involved in the transfusion process
2 Section CONTENTS Page No. 1. INTRODUCTION Relevant Contacts 4 2. PURPOSE 5 3. SCOPE 5 4. RESPONSIBILITIES, ACCOUNTABILITIES AND DUTIES Chief Executive Medical Staff Area Clinical Manager, Clinical Lead and Clinical Manager All Staff 6 5. PROCEDURE/IMPLEMENTATION Consent Prescribing Blood Products Requesting Blood Products Positive Identification of Patients Venepuncture Collection of Blood Products Receipt of Blood Products on the Ward Returning Blood Products to Blood Bank Administration of Blood Products Key Points Staff Responsible Receipt of blood products in the clinical area Inspection of Blood or Blood Products Responsibility for the identify check of the patient and the blood product the final bedside check Traceability Spillage Technical Aspects of the Administration of Blood Products Giving Sets Red Cells Platelets Cannula Drugs Disposal of Blood Bags Care and Monitoring of Patients Key Points Page 2 of 22
3 Staff Responsibility Observation of the Patient Completion of Transfusion Episode Reporting of Adverse Events/Reactions following or during Transfusion Staff Responsible for Reporting Adverse Events/Reactions Initial Clinical Assessment Investigation of a Suspected Transfusion Reaction Documentation of Adverse Events/Reactions Document of Transfusions Documentation in the Patient s Notes Documentation to be returned to Blood Bank Jehovah s Witness Policy and Patient or Family Refusal of Blood Transfusion Policy Jehovah s Witnesses Hospital Liaison Team TRAINING IMPLICATIONS MONITORING ARRANGEMENTS EQUALITY IMPACT ASSESSMENT SCREENING Privacy, Dignity and Respect Mental Capacity Act LINKS TO ANY ASSOCIATED DOCUMENTS REFERENCES APPENDICES (None) Page 3 of 22
4 1. INTRODUCTION This policy is adapted from the Doncaster and Bassetlaw NHS Foundation Trust s (DBHFT) policy (2014) for Blood Transfusions, as DBHFT are our blood product provider. The transfusion of blood and blood components is a potentially dangerous treatment. It involves a complex sequence of events to ensure that the right patient receives the right blood and strict procedures need to be in place, with checks at each stage (National Patient Safety Agency, 2006). Errors in the requesting, supply and administration of blood leads to significant risks to patients. Errors either in the collection or labeling of the sample for blood grouping and compatibility testing, or in the laboratory, or the failure of the final pre-transfusion checks account for a number of patient deaths in the UK each year. The incidence of wrong blood episodes has changed little over several decades. Variation in the practice of the administration of blood is becoming increasingly evident from audit, both local and national, and from the Serious Hazards of Transfusion (SHOT) reports. Consequently the Trust is committed to the use of competency assessment of all staff involved in the transfusion process and is committed to the actions set by National Patient Safety Agency (NPSA) Safety notice 14 (Right patient, Right blood). Blood transfusions in palliative care are not given routinely, but to treat problematic symptoms of anaemia, the cause of which in palliative patients is often multifactorial. Symptom burden to the patient, such as weakness, fatigue and breathlessness and likely benefit of the transfusion are important when deciding whether to transfuse or not (Waddell et al 2011). According to a recent Cochrane review (Preston et al 2012) a third of patients with advance cancer do not benefit from blood transfusions and the duration is often short for those who do. In fact there is the potential for harm to patients at the end of life due to fluid overload. Therefore decision to transfuse must be undertaken responsibly and on an individual basis. This policy is based on recognised guidelines and provides the Trust with local procedures for the ordering and administration of blood products and the management of transfused patients. 1.1 RELEVANT CONTACTS Blood Bank: Doncaster Royal Infirmary (DRI) Tel: (01302) Contact via DRI switchboard The Hospital Transfusion Team: Contact via DRI switchboard Consultant Haematologist: Contact via DRI switchboard Page 4 of 22
5 2. PURPOSE The purpose of this policy is to provide guidance, minimize risk and set out organizational arrangements for implementing best practice in relation to blood transfusions within the hospice setting. It sets out the procedures to which staff should adhere when requesting and administering a blood transfusion to patients. 3. SCOPE The policy applies to all staff within St John s Hospice involved in the process of blood transfusion, which includes prescribing, obtaining blood samples, collection, administering or returning blood. Other RDASH inpatient settings are not included in this policy as they do not administer blood transfusions 4. RESPONSILIBITIES, ACCOUNTABILITIES AND DUTIES 4.1 Chief Executive The Chief Executive has overall responsibility for ensuring the Trust meets its statutory and non-statutory obligations in respect of maintaining appropriate standards contained in this policy. 4.2 Medical Staff Medical staff are responsible for prescribing blood and blood products appropriate to the need of the patient and obtaining and administering consent. Medical staff must keep up to date with training regarding blood transfusions. 4.3 Area Clinical Manager, Clinical Lead and Clinical Manager It is the responsibility of the senior team to implement this policy and assist in the monitoring and compliance with the standards contained in this policy. Also to: Provide evidence that clinical staff can demonstrate competency and compliance with the content of this policy. Keep accurate, up-to-date training records of staff Blood Transfusion training. Clinical Lead, Clinical Manager and Ward Sister will attend additional training at DBHFT regarding blood transfusions in order to practically assess the inpatient Unit (IPU) nurses. Ensure any incidents involving the use of blood and blood products is reported using the Incident Reporting processes (Safeguard IR1) and investigated appropriately Page 5 of 22
6 4.4 All Staff It is the responsibility of all Registered Nurses and staff involved with the transfusion process to: Comply with the requirements of this policy regarding patient identification, which is essential for safe transfusion practice. Maintain accurate records and complete documentation required for audit trail of the transfusion. Monitor the patients and comply with the policy, reporting any suspected transfusion reactions to a member of the medical staff. The responsible Trust committee is the Clinical Quality Group, which is a sub-group of the Quality Assurance Sub Committee. 5. PROCEDURE/IMPLEMENTATION Blood Transfusions should only be in usual hospice working hours (Monday to Friday 9-5) and when a doctor is on site. Blood transfusions are not to be administered out of hours or at weekend. 5.1 Consent Patients have the right to know about the treatment being offered and the available alternatives. This should be done in a timely and understandable manner. It is essential to adhere to the Trust Policy for Consent to Examination or Treatment. Patients must be given information regarding the risks/benefits and alternatives, including the option of no transfusion. This is the responsibility of a doctor; however, signed consent is not required. It is helpful to provide patients with an information sheet outlining the risks and benefits of blood transfusion. For example, the National Blood Service has produced a number of patient information leaflets; these are available to print off, as required, from (download Do I need a blood transfusion? Staff will ensure information about risks/benefits and alternatives to blood transfusion are provided in a format to meet the person s individual requirements. Information sheets available from the Nation Blood Service on line to print off when needed. If a patient declines a transfusion the doctor in charge of the patient should be informed and any product on the ward immediately returned to the blood bank. The following information will be documented in the case notes using blood Page 6 of 22
7 prescription sheet WPR The discussion with the patient (details of the information provided to the patient) Reason for transfusion (clinical and laboratory data) The administration of the transfusion and any complications The clinical outcome Consent to proceed 5.2 Prescribing Blood Products Blood can only be prescribed by a doctor All staff prescribing must be aware of the risks/benefits of transfusion Training all doctors prescribing blood products must have the appropriate training/competencies completed as identified by the NPSA and follow both local and national guidelines. The prescription for blood and blood products must be signed and dated by a doctor on the appropriate blood prescription form (WPR26562). It is essential that the prescription sheet contains the patient identification details surname, first name, date of birth, patient NHS number. The prescription must specify: Consent obtained What components are to be transfused? Date of transfusion. The volume/number of units to be transfused. The rate of transfusion for red cells is usually hours Transfusion must be completed within 4 hours of removal from the authorised blood product transit box. Any other special instructions or requirements, e.g. Irradiated, CMV seronegative. Blood bank must be made aware of any special requirements. Requirement for any concomitant drugs. 5.3 Requesting Blood Products Blood can only be requested by a doctor or authorised non-medical staff, e.g. midwife or nurse with the appropriate training/competencies completed. All telephone requests must be followed by a written request form. Failure to do so will result in a delay in blood product provision. 5.4 Positive Identification of Patients Positive identification of the patient is essential and is based on: Page 7 of 22
8 Direct questioning of the patient by asking them to state their surname, first name and date of birth. This must always be done where the patient is judged capable of giving an accurate, reliable response. Staff should never lead the patient; the answer yes is not sufficient identification. Checking the details on the patient s identification wristband m a t c h those on the request form. (All inpatients and all patients undergoing a transfusion must have an ID band). All patients must have a patient identification number and an ID wristband with this number. When additional details become available the Blood Bank must be informed, but details must not be changed mid-incident. No wristband no transfusion. Positive identification of the patient must occur prior to: 5.5 Venepuncture Transfusion of blood and blood products Venepuncture Samples to be taken by a member of staff with a valid competency in venepuncture. All patients being sampled must be positively identified. Sample tubes should not be pre-labeled. The collection of the blood sample from the patient into the sample tubes and the sample labeling should be performed as one continuous uninterrupted event, involving one patient and one trained and competent healthcare worker only, samples to be labeled at the bedside using information taken from the patient s ID wristband. The Request Form: The request form must be completed in full (addressograph labels may be used) and include: Full name surname and forename. NHS number to be used. Hospital numbers from other hospitals are not accepted. Date of birth. Patient s location. Consultant. Number and type of blood products required. Date and time required. Patient s diagnosis/clinical details. Reason for the request (clinical indication) including most recent haemoglobin and/or platelet count if applicable, include date tested. Any special requirements (e.g. Irradiated, CMV negative). Date and time bled. Page 8 of 22
9 Gender. Requestor s name and signature. The request form should be signed by the person drawing the sample. Date of last transfusion. Any known antibodies. If pregnant within the last 6 months and RhD negative, please state the dates and doses of any prophylactic Anti-D immunoglobulin administered during this pregnancy. The Sample: Addressograph labels must not be used. The patient must be positively identified at the time a sample is taken. The sample tube must be labeled immediately after the blood has been taken (at the patient s bedside); sample tubes must not be pre-labeled. The sample tube must be labeled with the following: Full name surname and forename. NHS number hospital numbers from other hospitals are not acceptable. Date of birth. Gender. Signature of personal taking the blood sample. Ward or Clinical area. Date sample taken. Time sample taken. 5.6 Collection of Blood Products Good documentation of the blood audit trail is mandatory and a legal requirement Before collection, ensure the patient is ready to start the transfusion, baseline observations taken and has patent venous access. Ward staff arrange for blood products to be collected from the Blood Bank at Doncaster Royal Infirmary using RDaSH transport shuttle or approved taxi. Ward staff to contact a member of staff at the Blood Bank and advise transport arranged to collect blood product, ensuring appropriate clinical information is available relating to patient s name, NHS number and product requested. 5.7 Receipt of Blood Products on the Ward On arrival to the ward the blood must be immediately handed to the person responsible for administering the transfusion and not left in the nurses office or treatment room. Page 9 of 22
10 Blood should arrive in a validated cool storage box, this box must be sealed. The blood may remain in the validated cool storage box for no more than 2 hours. Once the validated cool storage box is opened the blood transfusion must be started within 30 minutes and transfused within 4 hours of removal from the validated cool storage box. NB Blood must not be stored in the ward drug or domestic fridges. 5.8 Returning Blood Products to Blood Bank Blood and blood products should be transfused as soon as possible after delivery to the inpatient unit (see section 5.7), i.e. within 30 minutes of removal from the validated cool storage box. If after collection of the blood a problem arises which prevents immediate transfusion, the unit must be returned to the Blood Bank within 2 hours of collection and the Blood Bank staff informed (if in a validated cool storage box). 5.9 Administration of Blood Products Key Points Final check must be conducted next to the patient by a trained and competent licensed healthcare professional who also administers the component including: All patients receiving a transfusion must be positively identified. All patient core identifiers on the patient s identification wristband must match the details on the blood component label. All blood components should be administered using a blood administration set with integral mesh filter. Transfusion should be completed within 4 hours of leaving temperature controlled storage box Staff Responsible Blood components are excluded from the current legal definition of medicinal products and the requirement for prescription by a registered medical practitioner, but are viewed as medicines for administration purposes. Blood components should only be administered by a licensed professional such as doctor (GMC registered), or a nurse holding current registration of the NMC Professional Register as a Registered General Nurse (RGN), who have had training in administering blood transfusions Receipt of blood products in the clinical area. The blood group and unit number of the blood product must be identical to that described on the attached blood tag label. The blood or blood component must be checked for compliance with any special requirements as specified on the prescription sheet, e.g. Page 10 of 22
11 Irradiated, CMV negative. The blood or blood component must be checked to ensure it has not passed its expiry date Inspection of Blood or Blood Products It is essential that staff administering blood or blood products inspect each unit prior to transfusion and return the unit to the Blood Bank if any defects are found. The inspection should pay attention to: The integrity of the pack by checking for leaks at the port or seams. Evidence of haemolysis in the plasma or at the interface between red cells and plasma. Evidence of unusual discoloration or turbidity. The presence of large clots Responsibility for the identity check of the Patient and the Blood Product The final bed side check Although two members of staff may be involved in the checking procedure, it is recommended that one member of staff should be responsible for carrying out the identity check of the patient and the unit of blood at the patient s bedside. The member of staff must be a doctor or a nurse holding current registration of the NMC Professional Register as a Registered General Nurse (RGN). Positive identification of the patient the final check This is ESSENTIAL and is based on: Direct questioning of the patient by asking their surname, first name and date of birth in the case of patients who are judged capable of giving an accurate reliable response. Checking the details on the patient s identity band. Checking the ID band is mandatory even if the patient can give his/her identity. The surname, first name, gender, date of birth and unique identification number must be identical with: The compatibility label attached to the blood component (also check the blood tag label is on the correct bag by checking the donation number and product type with the information on the front of the blood product bag). Patient s identification wristband. NB Only the labeled blood product and the patient s identity band are to be used as part of the final bedside check, not a compatibility form or prescription sheet. Page 11 of 22
12 Any discrepancies identified by these checks should be reported to the Blood Bank immediately and the transfusion delayed until clarification of any point is made. The transfusion of blood and blood components should begin as soon as possible. The prescription sheet must be readily available during the transfusion. The report must then be filed in the medical noted following completion Traceability On completion of these checks staff must sign the blood transfusion compatibility report form, the peel off sticker from the blood tag label (which is then attached to the prescription sheet (WPR26562) and the blood tag for return to Blood Bank. The start and finish time of the transfusion must be recorded on the blood prescription sheet (WPR26562). The completed detachable blood tag must be returned to Blood Bank immediately following transfusion to enable full traceability and ensure the Trust fulfills its legal requirements as defined by BSQR The return of the tags is mandatory. The efficacy/outcome/benefit of this transfusion must be recorded in the patient s notes Spillage Where a spillage of blood or blood products occurs, the infection prevention and control policy Management of Blood and Body Fluid Spillages should be followed Technical Aspects of the Administration of Blood Products Giving Sets Adhere to strict aseptic techniques when handling blood or blood components. Refer to Aseptic Technique and Aseptic Non Touch Technique Policy. Blood products should be transfused through a sterile giving set designed for the procedure. Filter size micron filter is required. Drugs must not be added to blood products under any circumstances. Page 12 of 22
13 Red Cells Electronic infusion pumps may damage blood cells and should not be used for administration of red cells unless the manufacturers have verified them as safe to use for this purpose and staffs have been trained in their use. To prevent bacterial growth a new giving set must be used after 12 hours or after 3 units, whichever is earlier. Some giving sets may be issued with different instructions. If the usage life of a giving set is shorter, always follow the manufacturer s instructions. Start transfusion as soon as the unit is received from Blood Bank. Each unit of blood must be used within a maximum of four hours from leaving Blood Bank fridge or validated blood storage box, usually red cells are transfused over 2-3 hours. Flushing through the remainder of the blood in the line with Sodium Chloride 0.9% is not recommended. All blood products are leucocyte depleted. Usually supplied as packed red cells in additive solution (SAGM) Platelets (PLT) (Mean Volume 202ml) A standard blood or platelet giving set should be used for the administration of platelets. Platelets should be transfused through a new clean standard blood or platelet giving set (not one already used for blood). Never put platelets in a fridge. Start infusion as soon as the pack is received from the Blood Bank. Infuse stat or maximum time 30 minutes in an adult Cannula Drugs A 20 gauge cannula is the minimum size required for transfusion. The size of cannula chosen can affect the speed at which the blood can be transfused. Drugs must never be added to blood and products under any circumstances. Drugs should not be administered through the same cannula when transfusion of blood or blood products is in progress Disposal of Blood Bags On completion of the transfusion the empty bag should be retained for a Page 13 of 22
14 period of 24 hours and then discarded via the offensive hygiene waste i.e. yellow bag with black stripes if there is no evidence of a transfusion reaction. The empty bag will be stored in the designated sluice area in the nominated and labeled container. The Nurse in Charge will ensure appropriate disposal following the 24 hour period Care and Monitoring of Patients Key Points Observations should be undertaken for every unit transfused. Minimum monitoring of the patient should include: Regular visual observation throughout the transfusion episode. Pre-transfusion pulse (P), blood pressure (BP), temperature (T), respiratory rate (RR) and O2 saturation. To be taken no more than 60 minutes before starting transfusion. A complete set of vital signs should be taken 15 minutes after the start of each component transfusion for all patients. More frequent observations may be required, e.g. rapid transfusion, or patients who are unable to complain of symptoms which would raise suspicion of a developing transfusion reaction. If the patient shows signs or symptoms of a possible transfusion reaction, the vital signs should be monitored and recorded and appropriate action taken (see section 5.12). Vital signs must continue to be monitored every 5-15 minutes depending on the severity of the reaction and until reaction has resolved or escalated to hospital. Post transfusion observations should be taken and recorded not more than 60 minutes after the end of the component transfusion. Patients should be observed during the subsequent 24 hours or, if discharged, counseled about the possibility of late adverse reactions. Clinical areas should ensure that systems are in place to ensure patients have 24 hour access to clinical advice Staff Responsible The member of staff responsible for the care and monitoring of the patient during the transfusion must be a nurse holding current registration of the NMC Professional Register as a Registered General Nurse (RGN), or a doctor. They must take charge of the patient during the transfusion and be responsible for ensuring that all care and monitoring of the patient is performed Observation of the Patient It should be stressed to the patient the importance of reporting any adverse effects that they may feel, including shivering, rashes, flushing, shortness of Page 14 of 22
15 breath, pain in the extremities or in the loins. Visual observation of the patient is often the best way of assessing the condition of the patient during transfusion. Transfusions should be given in clinical areas where patients can be readily observed by members of the clinical staff. Patients should be able to alert staff if they experience any adverse effects. The start and finish time of the transfusion must be recorded on the peel off sticker from the blood tag which is attached to the blood prescription sheet (WPR26560). Vital signs temperature, pulse, blood pressure, respirations and O2 saturation MUST be measured and recorded before the start of each unit of blood or blood component, and at the end of each transfusion episode. During the first 15 minutes of the transfusion of each unit the patient MUST be regularly observed (most reactions will occur in this time and will require immediate attention) and the patient s vital signs MUST be monitored and recorded. Further observations during the transfusion of each unit of blood or blood product need only be taken should the patient become unwell or show signs of a transfusion reaction or if advised by Blood Bank Completion of Transfusion Episode If a further blood component unit is required: Repeat the administration/identify check with each unit. If no further units are prescribed: Remove the blood administration set. Ensure all transfusion documentation is completed and the tag is returned immediately to Blood Bank. Return any unused blood products to the blood bank Reporting of Adverse Events/Reactions following or during Transfusion Staff Responsible for Reporting Adverse Events/Reactions Initial treatment of an Adverse Transfusion Reaction (ATR) is not dependent on classification but should be directed by symptoms and signs. Treatment of severe reactions should not be delayed until the results of investigations are available. Patients should be asked to report symptoms which develop within 24 hours Page 15 of 22
16 of completion of the transfusion Initial clinical assessment Initial clinical assessment seeks to quickly identify those patients with serious or life threatening reactions so that immediate treatment/resuscitation can be initiated. Immediate management of ATR If a patient develops new symptoms or signs during a transfusion, this should be stopped temporarily, but venous access maintained. Identification details should be checked between the patient, their identity band and the compatibility label of the blood component. Perform visual inspection of the component and assess the patient with standard observations. Mild Adverse Reactions. For patients with mild reactions, such as pyrexia (temperature of > 38 o C and a rise of 1-2 o C), and/or pruritus or rash but without other features, the transfusion may be continued with appropriate treatment and direct observation. If at any time a transfusion reaction is suspected, the doctor in charge of the patient should be contacted by the nurse responsible for the patient during the transfusion and should review the patient promptly. Any adverse events should be recorded in the patient s notes and logged on the blood prescription sheet (WPR26562). It is the doctor s responsibility to ensure the adverse reaction is reported to Blood Bank. It is the responsibility of Blood Bank staff to report the event to senior Blood Bank staff or the Transfusion Practitioner to enable external reporting to SABRE (Serious Adverse Blood Reactions and Events) and/ or SHOT if appropriate. Patients with mild isolated febrile reactions may be treated with oral Paracetamol ( mg in adults). Patients with mild allergic reactions may be managed by slowing the transfusion and treatment with an antihistamine. Severe Adverse Reactions Management is guided by rapid assessment of symptoms, clinical signs and severity of the reaction. The transfusion must be stopped immediately. Page 16 of 22
17 The blood administration set should be changed and venous access maintained using Sodium Chloride 0.9% running slowly to keep the vein open. The doctor must be informed and must assess the patient. Escalate to DRI via 999 ambulance (all patients with severe reaction) A Consultant Haematologist must be informed. The reaction should be reported immediately to the Blood Bank, who will issue a Transfusion Reaction Investigation sheet. Follow the instructions carefully, complete the sheet and return to Blood Bank as instructed along with any remaining blood products which may have been involved in the reaction Whilst awaiting the ambulance - the vital signs should be monitored immediately, recorded, and appropriate action taken. Vital signs must continue to be monitored every 5-15 minutes depending on severity of reaction and until the possible reaction has resolved. The volume and colour of any urine passed should be recorded in the patient s notes. Anaphylaxis Anaphylaxis should be treated with intramuscular adrenaline (epinephrine) according to UKRC guidelines. Patients who are thrombocytopenic or who have deranged coagulation should also receive intramuscular adrenaline if they have an anaphylactic reaction Hypotension If a patient being transfused for haemorrhage develops hypotension, careful clinical risk assessment is required. If the hypotension is caused by haemorrhage, continuation of the transfusion may be life-saving. In contrast, if the blood component is considered the most likely cause of hypotension, the transfusion must be stopped or switched to an alternative component and appropriate management and investigation commenced. Febrile symptoms of moderate severity If a patient develops sustained febrile symptoms or signs of moderate severity (temperature > 39 o C or a rise of > 2 o C and/or systemic symptoms such as chills, rigors, myalgia, nausea or vomiting), bacterial contamination or a haemolytic reaction should be considered Investigation of a Suspected Transfusion Reaction The completed form and samples should be sent immediately to the Blood Page 17 of 22
18 Bank with the Blood Product bag(s) and giving set. Samples required: Group & save, FBC, U/E, LFT, coagulation screen, blood cultures. The Blood Bank will report on its investigation as soon as possible. No further transfusion of units currently cross-matched should be undertaken until the blood bank investigation is complete this may be mitigated by the Consultant Haematologist depending on circumstances Documentation of Adverse Events/Reactions Any adverse events should be recorded in the patient s notes and logged on the blood prescription sheet (WPR26562). Complete an incident form (IR1) and ensure a copy is sent to Blood Bank. All adverse events related to blood/blood product transfusion will be reviewed by the Hospital Transfusion Committee. Serious adverse events should be reported to the MHRA (Medicines and Healthcare Products Regulation Agency) via SABRE (Serious Adverse Blood Reactions and Events) and to SHOT (Serious Hazards of Transfusion) via the Blood Bank. Suspected cases of transfusion-transmitted infection should be reported immediately to the local Transfusion Centre via the Blood Bank Documentation of Transfusions Full documentation of transfusion is mandatory and a legal requirement Documentation in the Patient s Notes A permanent record of the transfusion must be held in the patient s medical notes, including: A complete record of the transfusion on the blood prescription sheet (WPR26562), with the following information: o Start and finish time of the transfusion on the blood prescription sheet (WPR26562). o The indication for the transfusion. o The type and number of blood products used. o Whether or not the desired effect was achieved. o The occurrence and management of any adverse effect. o The peel off sticker from the blood tag must be attached to the prescription sheet Page 18 of 22
19 The sheets used for nursing observations during the transfusion Documentation to be returned to Blood Bank The return of the tags is mandatory The completed detachable blood tag must be returned to Blood Bank immediately following transfusion to enable full traceability and ensure the Trust fulfills its legal requirements as defined by BSQR The return of the tags is mandatory Jehovah s Witness Policy and Patient or Family Refusal of Blood Transfusion Policy Some people may refuse blood transfusion for a variety of reasons. The aim of this policy is to ensure that Jehovah s Witnesses beliefs are acknowledged and respected and to provide information with regard to the treatment of all patients who refuse blood transfusion. If refusal by non-jehovah s Witnesses is based on fear of transfusion transmitted infection, the risks should be clearly explained. Refusal of blood transfusion should be carefully documented in the patient s medical notes by the consultant/most senior doctor present, with the reasons given together with date, time and signature. Jehovah s Witnesses have definite objections to blood transfusions for both religious and medical reasons. Jehovah s Witnesses rule out the transfusion of red cells, whole blood, fresh frozen plasma, platelets and white cells, Predonation (PAD) and may refuse to donate bone marrow/stem cells. Anti-D immunoglobulin and Cryoprecipitate may be accepted and should be offered where appropriate. However this is not available in the hospice and would need to be explained to the patient. Following consent, transfer to DBHFT would need to be arranged Jehovah s Witnesses Hospital Liaison Team Contact the Jehovah s Witnesses Hospital Liaison Committee with regard to alternative care or to locate doctors experienced in the management of Jehovah s Witnesses. The following website has additional resources: Hospital Information Services (United Kingdom) 24-Hour Contact Number: (020) Hospital Information Services for Jehovah s Witnesses IBSA House, The Ridgeway, London, NW7 1RN Page 19 of 22
20 6. TRAINING IMPLICATIONS Staff groups requiring training All staff involved in the process of blood transfusion, which includes prescribing, obtaining a blood sample, collect, administering or returning blood. Blood Transfusion Policy How often Length of Delivery should this be training method undertaken Annually. Competence assessment every 2 years. 1 2 hours Face to face/ e- learning Training delivered by whom NHS England E-learning and Senior nursing team who have attended further training Where are the records of attendance held? Electronic Staff Record system (ESR) All members of staff involved in the process of blood transfusions, which include prescribing, obtaining a blood sample, collecting, administering or returning blood, must have completed training on Blood transfusions and be assessed as competent. National guidance (BCSH 2012) states update training may be performed using an E-learning package appropriate to role and undertake competency assessments every 2 years. All training will be recorded using electronic staff records and also held by their line manager. Clinical Lead and the clinical manager will receive additional training provided by DBHFT regarding blood transfusions in order to practically assess the hospice nurses All training must be documented and records retained. Staff will receive instruction and direction regarding Blood Transfusion from a number of sources: Policies and Procedures Manuals Line Manager/ Clinical Lead Training via NHS England E-learning Communication methods (e.g. Team Brief/team meetings) 7. MONITORING ARRANGEMENTS Area for Monitoring How Who by Reported to Frequency Monitoring and review of transfusion process Audit Hospital Transfusion Team, DRI Hospital Transfusion Committee Annual Compliance with Policy re documentation and traceability Return of Blood tags to Blood Bank Blood Bank staff Ward Each transfusion Page 20 of 22
21 8. EQUALITY IMPACT ASSESSMENT SCREENING The completed Equality Impact Assessment for this Policy has been published on this Policy s webpage on the Trust Policy website. 8.1 Privacy, Dignity and Respect The NHS Constitution states that all patients should feel that their privacy and dignity are respected while they are in hospital. High Quality Care for All (2008), Lord Darzi s review of the NHS, identifies the need to organise care around the individual, not just clinically but in terms of dignity and respect. Indicate how this will be met No issues have been identified in relation to this policy. As a consequence the Trust is required to articulate its intent to deliver care with privacy and dignity that treats all service users with respect. Therefore, all procedural documents will be considered, if relevant, to reflect the requirement to treat everyone with privacy, dignity and respect, (when appropriate this should also include how same sex accommodation is provided). 8.2 Mental Capacity Act Central to any aspect of care delivered to adults and young people aged 16 years or over will be the consideration of the individuals capacity to participate in the decision making process. Consequently, no intervention should be carried out without either the individuals informed consent, or the powers included in a legal framework, or by order of the Court Therefore, the Trust is required to make sure that all staff working with individuals who use our service are familiar with the provisions within the Mental Capacity Act. For this reason all procedural documents will be considered, if relevant to reflect the provisions of the Mental Capacity Act 2005 to ensure that the interests of an individual whose capacity is in question can continue to make as many decisions for themselves as possible. Indicate How This Will Be Achieved. All individuals involved in the implementation of this policy should do so in accordance with the Guiding Principles of the Mental Capacity Act (Section 1) Page 21 of 22
22 9. LINKS TO ANY ASSOCIATED DOCUMENTS Trust Website:- Management of blood and body fluid spillages policy, Clinical Policies, Infection Prevention and Control Aseptic technique and aseptic non-touch technique policy, Clinical Policies, Infection Prevention and Control Standard Precautions policy, Clinical Policies, Infection Prevention and Control Hand hygiene policy Clinical Policies, Infection Prevention and Control Policy pathology specimens, clinical policies, infection prevention and control Waste policy, corporate polices, estates and facilities Policy for Consent to Care and Treatment, general clinical, admissions/access to service 10. REFERENCES British Committee for Standards in Haematology (2012) Guideline on the Administration of Blood Components. BCSH, London. British Committee for Standards in Haematology (2012) Guideline on the Investigation and Management of Acute Transfusion reactions. BCSH, London. Doncaster, Bassetlaw NHS Foundation Trust (2014) Blood Transfusion Policy Malia, C (2015) Standard operating procedure: transfusion of blood and blood components. St Gemma s Hospice, Leeds National Patient Safety Agency (2006) Safer practice notice 14: Right Patient, Right Blood. Available at (accessed 9/10/17). Preston, N. Hurlow, A. Brine, J. Bennett, M. (2012) Blood transfusions for anaemia in patients with advanced cancer (review) The Cochrane Collaboration. John Wiley & Sons Ltd. London. Page 22 of 22
Sample. A guide to development of a hospital blood transfusion Policy at the hospital level. Effective from April Hospital Transfusion Committee
Sample A guide to development of a hospital blood transfusion Policy at the hospital level Name of Policy Blood Transfusion Policy Effective from April 2009 Approved by Hospital Transfusion Committee A
More informationBlood Products Policy
Blood Products Policy Originator: Corinne Revens, Ward Sister Jane Creed, Senior Registered Nurse Miranda Green, Registered Nurse Review date: August 2013 Revision date: August 2015 Approved by: Clinical
More informationAdministration of blood components. Denise Watson Patient Blood Management Practitioner 11th January, 2016
Administration of blood components Denise Watson Patient Blood Management Practitioner 11th January, 2016 Introduction British Committee for Standards in Haematology guidelines Administration process Case
More informationSafe Blood Transfusion
Safe Blood Transfusion Cardiff & Vale uhb & Welsh Blood Service Education Sub-group Objectives Complex pathway Overview ~ pre-transfusion blood sampling ~ collection from blood bank fridge ~ administration
More informationBLOOD TRANSFUSION POLICY
Title: BLOOD TRANSFUSION POLICY Ref: 0219 Version 11 Classification: Guideline Directorate: Laboratory Medicine Due for Review: 15/12/2020 Document Control Responsible Consultant Haematologist and Transfusion
More informationBlood / Blood Products Transfusion A Liquid Transplant
Blood / Blood Products Transfusion A Liquid Transplant Caroline Holt Specialist Practitioner of Transfusion caroline.holt@tgh.nhs.uk Tel : 922 5484 Mob: 07759260044 The Transfusion Team Gillian Lewis Blood
More informationPOLICY FOR THE TRANSFUSION OF BLOOD AND BLOOD COMPONENTS
POLICY FOR THE TRANSFUSION OF BLOOD AND BLOOD COMPONENTS Document Author Written By: Transfusion Practitioner / Transfusion Laboratory Manager Authorised Authorised By: Chief Executive Date: July 2015
More informationBlood Administration for Community Patients Policy
Blood Administration for Community Patients Policy Policy Title: Blood Administration for Community Patients Policy Policy Reference Number: PrimCare08/15 Implementation Date: Review Date: July 2010 Responsible
More informationTrust Policy for Blood Transfusion
Trust Policy for Blood Transfusion Approval and Authorisation Reviewed by Job Title Date Simon Middleton Chair of Hospital Transfusion Committee 03.09.2010 Rebecca Sampson Consultant Haematologist 01.09.2010
More informationCompetency Framework for the Administration of all Blood Products
Framework for the Administration of all Blood Products Ref No. Authors Others Consulted during preparation Date Created December 2006 Date reviewed March 2007 Date approved Implementation date April 2007
More informationHoist and Sling for Safer Patient Use Policy
Hoist and Sling for Safer Patient Use Policy DOCUMENT CONTROL: Version: 4 Ratified by: Quality and Safety Sub Committee Date ratified: 30 January 2017 Name of originator/author: Back Care Advisor Name
More informationCompetency Assessment for Non Medical Prescribing of Blood and Blood Components
Competency Assessment for Non Medical Prescribing of Blood and Blood Components Name of Candidate (please print). Ward/Department:... Band/Job Title:.. Professional Registration Number Date initial in-house
More informationBlood and Blood Products Administration
NCAL Patient Care Services 2016 Blood and Blood Products Administration Objectives: On completing this module, you will be able to: Identify blood group systems Describe compatibility requirements List
More informationDESCRIPTION/OVERVIEW This document standardizes the transfusion of packed red blood cells and/or other blood components.
Applies To: UNM Hospitals & UNMCC Responsible Department: Blood Bank Revised: 5/2017 Procedure Patient Age Group: ( ) N/A (X) All Ages ( ) Newborns ( ) Pediatric ( ) Adult DESCRIPTION/OVERVIEW This document
More informationRight blood, right patient, right time. RCN guidance for improving transfusion practice. Past review date Use with caution
Right blood, right patient, right time RCN guidance for improving transfusion practice Acknowledgements We would like to thank everyone who reviewed this edition of Right blood, right patient, right time:
More informationAdministration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure
Administration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Quality and Standards Group Date
More informationLessons for Transfusion Laboratory Staff. from the 2007 SHOT Report SHOT SERIOUS HAZARDS OF TRANSFUSION
Lessons for Transfusion Laboratory Staff from the 2007 SHOT Report SERIOUS HAZARDS OF TRANSFUSION SHOT The Serious Hazards of Transfusion Scheme (SHOT) is a UK-wide confidential enquiry that collects data
More informationCyclophosphamide INFUSION Infusion 4 Plus
Cyclophosphamide Infusion Day DEPARTMENT OF RHEUMATOLOGY DAY CASE ADMISSION RECORD PATIENT DAY CASE BOOKING REQUEST To be completed by Consultant, Registrar requesting day case Admission Hospital No. Forename
More informationBlood Transfusion Policy. Version Number: 6.1 Controlled Document Sponsor: Controlled Document Lead: On: December 2014.
Blood Transfusion Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Clinical The policy describes the framework and principles required to deliver best transfusion
More informationPATIENT IDENTIFICATION POLICY
PATIENT IDENTIFICATION POLICY DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Effectiveness Committee Date ratified: 12 th January 2012 Name of originator/author: Clinical Policy Advisor Name of responsible
More informationADMINISTRATION OF BLOOD PRODUCTS (RED CELLS, PLATELETS, PLASMA, & CRYOPRECIPITATE) NICU SYRINGE METHOD
PURPOSE ADMINISTRATION OF BLOOD PRODUCTS To provide guidelines for the administration of blood products (red blood cells, platelets, plasma and cryoprecipitate) via syringe delivery in NICU SITE APPLICABILITY
More informationACCOUNT NO. MED. REC. NO. NAME BIRTHDATE. Patient Identification ALL ORDERS MUST BE MARKED IN INK WITH A CHECKMARK ( ) TO BE ACTIVE.
PO7071 *PO7071* Page 1 of 4 ALL MUST BE MARKED IN INK WITH A CHECKMARK ( ) TO BE ACTIVE. Weight: kg Height: cm Allergies: Treatment Start Date: Date(s) of Transfusion(s): Current Labs: WBC: Hgb/Hct: Platelets:
More informationREVISED: 7/03, 03/05, 04/08, 3/10, 11/11, 09/13, 3/14,1/15, 4/16
TITLE/DESCRIPTION: DEPARTMENT: PERSONNEL: BLOOD PRODUCT ADMINISTRATION CLINICAL LABORATORY ALL HOSPITAL EMPLOYEES EFFECTIVE DATE: 10/95 REVISED: 7/03, 03/05, 04/08, 3/10, 11/11, 09/13, 3/14,1/15, 4/16
More informationHYWEL DDA LOCAL HEALTH BOARD. Transfusion Policy. Completed Action: Addresses all aspects of transfusion with blood and blood components
Policy Number: 278 Supersedes: Standards For Healthcare Services No/s Version No: 1 Date Of Review: Reviewer Name: Completed Action: Approved by: Date Approved: New Review Date: Brief Summary of Document:
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FMD. Patient s first names.
Patient identifier/label: Page 1 of 6 Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital NHS number
More informationPolicy for the Administration of Blood and Blood Components
Policy for the Administration of Blood and Blood Components TARGET AUDIENCE: All Staff involved in the prescription, collection and administration of blood and blood components POLICY CATEGORY: Blood Transfusion
More informationAn Overview of Blood Transfusion Link Nurse Meeting MARY METCALFE/CARMEL PARKER TRANSFUSION PRACTITIONERS 7 TH SEPTEMBER 2007
An Overview of Blood Transfusion Link Nurse Meeting MARY METCALFE/CARMEL PARKER TRANSFUSION PRACTITIONERS 7 TH SEPTEMBER 2007 Reasons for Transfusion Massive blood loss Anaemia Surgery Critical care setting
More informationRoot Cause Analysis of Transfusion Incidents The Leeds Experience
Root Cause Analysis of Transfusion Incidents The Leeds Experience Richard Haggas Quality Manager, Blood Transfusion Lab Claire Thompson Transfusion Nurse Practitioner, Hospital Transfusion Team LTH Transfusion
More informationPOLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case
POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case DOCUMENT NO: DN116 Lead author/initiator(s): Sarah Woodley Community Health Services Pharmacist sarah.woodley@ccs.nhs.uk
More informationSection 132 of the Mental Health Act 1983 Procedure for Informing Detained Patients of their Legal Rights
Section 132 of the Mental Health Act 1983 Procedure for Informing Detained Patients of their Legal Rights DOCUMENT CONTROL: Version: 11 Ratified by: Mental Health Legislation Sub Committee Date ratified:
More informationFY 15 BLOOD ADMINISTRATION/REACTION
1 FY 15 BLOOD ADMINISTRATION/REACTION Patient Care Services Policies PCS-205 Blood and Blood Components Transfusion: Initiation & Maintenance PCS-206 Blood and Blood Components: Transfusion Reaction PCS-207
More informationMedicine Protocol for the Administration of Inactivated Influenza Vaccine (Split Virion) BP Version 1, June 2017
Medicine Protocol for the Administration of Inactivated Influenza Vaccine (Split Virion) BP to nurses, midwives, healthcare workers, agency staff, contract workers and volunteers by registered nurses and
More informationSt. Vincent s East Page 1 of 5
St. Vincent s East Page 1 of 5 TITLE: PATIENT CARE PRACTICE GUIDELINE CARE OF PATIENTS BLOOD AND BLOOD COMPONENTS - ADMINISTRATION FACILITY: FUNCTION: ORIGINATING DEPT: St. Vincent s East HOSPITAL SHARED
More informationPROCEDURE FOR TAKING AND LABELLING A TRANSFUSION SAMPLE AND COMPLETING THE REQUEST FORM
Mid-West Area Hospitals Page 1 of 5 Edition No.: 01 PROCEDURE FOR TAKING AND LABELLING A TRANSFUSION SAMPLE AND COMPLETING THE REQUEST FORM EDITION No 01 EFFECTIVE DATE 5 th February 2013 REVIEW INTERVAL
More informationDocument Details. notification of entry onto webpage
Document Details Title Patient Group Direction (PGD) Administration of sodium chloride 0.9% injection by registered professionals Trust Ref No 1987-38096 Local Ref (optional) Main points the document As
More informationBlood Transfusion Policy. Clinical Policies and Guidelines. Hospital Transfusion Committee. Blood Transfusion
Blood Transfusion Policy SharePoint Location SharePoint Index Directory Clinical Policies and Guidelines Haematology and Blood Transfusion Year and Version Number 2012 version 7 Central index number on
More informationLaboratory Request Form Completion and Specimen Labelling Reference Number:
This is an official Northern Trust policy and should not be edited in any way Laboratory Request Form Completion and Specimen Labelling Reference Number: NHSCT/12/582 Target audience: This policy is directed
More informationStandard Operating Procedure for Patients Referred for Blood Transfusion to Louth Clinical Decision Unit by General Practitioners.
Standard Operating Procedure for Patients Referred for Blood Transfusion to Louth Clinical Decision Unit by General Practitioners. Reference number: G_CS_87 Version: 1 Ratified by: LCHS Trust Board Date
More informationReviewed 8/31/2013. Susan Parrish MSN RN
Reviewed 8/31/2013 Susan Parrish MSN RN After completion of this self study packet, the nurse should be able to: Identify the required components of the physician's order for blood transfusion products.
More informationHAEMOVIGILANCE. Ms. Emma O Riordan Haemovigilance, CNM2 (Acting) Ms. Bríd Doyle, MSc. FAMLS. Haemovigilance Co-ordinator, (Acting)
HAEMOVIGILANCE a set of surveillance procedures covering the whole transfusion chain from the collection of blood and its components to the follow-up of its recipients, intended to collect and assess information
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Injectable Medicines Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Injectable Medicines Policy Version No.: 4.3 Effective From: 24 March 2017 Expiry Date: 21 January 2019 Date Ratified: 11 January 2017 Ratified By:
More informationSpecimen and Request Form Labelling Policy
Directorate of Pathology Specimen and Request Form Labelling Policy This procedural document supersedes: Policy for Specimen and Request Form Labelling PAT/T v.5. Did you print this document yourself?
More informationA Guide To Safe Blood Transfusion Practice
A Guide To Safe Blood Transfusion Practice Introduction To Blood Transfusion Safety Marie Browett, Pavlina Sharp, Fiona Waller, Hafiz Qureshi, Malcolm Chambers (on behalf of the UHL Blood Transfusion Team)
More informationPROCEDURE FOR BLOOD COMPONENTS/PRODUCTS PRE- ADMINISTRATION CHECKS AND TRACEABILITY
Mid-West Area Hospitals Page 1 of 6 Edition No.: 02 PROCEDURE FOR BLOOD COMPONENTS/PRODUCTS PRE- ADMINISTRATION CHECKS AND TRACEABILITY EDITION No 02 EFFECTIVE DATE 5 th February 2013 REVIEW INTERVAL AUTHORISED
More informationGuidelines for In-patient and Residential staff. Staff in Mental Health and Learning Disability In-
Guidelines for In-patient and Residential staff in Mental Health and Learning Disability Services for contacting the On call -Training Grade Doctor/GP DOCUMENT CONTROL Version 4.2 Ratified by Quality and
More informationHepatitis B Immunisation procedure SOP
Hepatitis B Immunisation Procedure SOP Standard Operating Procedure (SOP) Ref No: 1992 Version: 3 Prepared by: Karen Bennett Presented to: Care and Clinical Policies Sub Group Ratified by: Care and Clinical
More informationCAUTION: Refer to the Document Library for the most recent version of this policy. Blood Transfusion Policy. Pathology Transfusion.
Directorate Department Year Version Number Central Index Number Endorsing Committee Date Endorsed Approval Committee Date Approved Author Name and Job Title Key Words (for search purposes) Date Published
More informationHome therapy programme
Home therapy programme A guide for GPs Information for GPs Clinical Immunology and Allergy Unit page 2 of 8 Introduction This booklet is to give GPs an outline of the immunoglobulin replacement home therapy
More informationBetter Blood Transfusion & anti-d Immunoglobulin
Better Blood Transfusion & anti-d Immunoglobulin - an analysis of adverse events reports from the Serious Hazards of Transfusion scheme Tony Davies - Transfusion Liaison Practitioner SHOT / NHSBT The Royal
More informationAnaphylactic Reaction Emergency Treatment Reference Number:
This is an official Northern Trust policy and should not be edited in any way Anaphylactic Reaction Emergency Treatment Reference Number: NHSCT/12/551 Target audience: Nursing Staff Groups included are:
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE TRANSFUSION OF BLOOD COMPONENTS AND PRODUCTS SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Provincial Transfusion Medicine Network Not applicable DOCUMENT #
More informationRegistered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework
Registered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework Name: Location: Date commenced: Contents Competency: Page No: Page 1. Core: Introduction Demonstrate knowledge that
More informationOral Ibrutinib (single agent)
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM IBRUTINIB Patient s surname/family name Patient s first names Date of birth Hospital Name: NHS number (or other
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) CO-CODAMOL 30/500 TABLETS FOR MINOR INJURIES UNITS Trust Ref No 1956-35206 Local Ref (optional) Main points the document treatment of moderate pain
More informationIrradiated blood products - Pathway for requesting To provide healthcare professionals with clear guidance on the use of irradiated blood products.
Document Title: Document Purpose: Document Statement: Document Application: Responsible for Implementation: Irradiated blood products - Pathway for requesting To provide healthcare professionals with clear
More informationSARASOTA MEMORIAL HOSPITAL
SARASOTA MEMORIAL HOSPITAL TITLE: ISSUED FOR: NURSING PROCEDURE Nursing DATE: REVIEWED: PAGES: RESPONSIBILITY: RN, LPN I, LPN II Per Job Description 03/93 2/18 1 of 6 PURPOSE: KNOWLEDGE BASE: To provide
More informationQuality Management Training for Blood Transfusion Services
EHT/05.03 E Restricted Quality Management Training for Blood Transfusion Services Modules 13 15 This publication forms part of a series of training materials developed specifically for use in WHO Quality
More informationAMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and Examination Policy
AMPH-PGN-10 Practice Guidance Note Intramuscular Injection (IMI) V01 Date Issued Planned Review PGN No: Issue 1 Sep 2017 Sep 2020 AMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 + RITUXIMAB
Patient identifier/label: Page 1 of 6 FORM CHOP 21 + RITUXIMAB Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital
More informationStandard 1: Governance for Safety and Quality in Health Service Organisations
Standard 1: Governance for Safety and Quality in Health Service Organisations riterion: Governance and quality improvement system There are integrated systems of governance to actively manage patient safety
More informationRecommendations from National Patient Safety Agency alerts that remain relevant to the Never Events list 2018
Recommendations from National Patient Safety Agency alerts that remain relevant to the Never Events list 2018 January 2018 We support providers to give patients safe, high quality, compassionate care within
More informationAdministration of Intrathecal Cytotoxic Chemotherapy in NHS Grampian
Administration of Intrathecal Cytotoxic Chemotherapy in NHS Grampian Lead Author/Coordinator: Jeff Horn / Sarah Howlett Macmillan Haematology CNS/ Pharmacist Reviewer: Gavin Preston Consultant Haematologist
More informationDISTRICT NURSING and INTERMEDIATE CARE
CLINICAL GUIDELINES DISTRICT NURSING and INTERMEDIATE CARE Schedule of guidelines attached: DNICT03 Community Procedure for the Administration of Intravenous Drugs via Bolus The guidelines scheduled above
More informationSARASOTA MEMORIAL HEALTH CARE SYSTEM CORPORATE POLICY
SARASOTA MEMORIAL HEALTH CARE SYSTEM CORPORATE POLICY TITLE: ADMINISTRATION OF BLOOD AND EFFECTIVE DATE: REVIEWED/REVISED DATE: POLICY TYPE: 10/15/79 08/31/17 Clinical 1 of 7 Non-Clinical Job Title of
More informationRequesting a Second Opinion Policy
Requesting a Second Opinion Policy DOCUMENT CONTROL: Version: 2 Ratified by: Quality and Safety Sub Committee Date ratified: 31 July 201 Name of originator/author: Doncaster Locality Manager, Adult Mental
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX)
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX) Patient s surname/family name Patient s first names Date of birth Hospital
More informationSt Mary s Church of England Primary School. First Aid Policy
St Mary s Church of England Primary School First Aid Policy 1. Aims To act safely, promptly and effectively with accidents and emergencies To use basic first aid equipment To maintain records on the nature
More informationPatient Self Administration of Intravenous (IV) Antibiotics at Home
Trust Policy Document Ref. No: PP(16)319 Patient Self Administration of Intravenous (IV) Antibiotics at Home For use in: For use by: For use for: Document owner: Status: Clinical Areas Clinical Staff Patient
More informationSt John the Evangelist RCP School
St John the Evangelist RCP School Children with Medical Conditions Policy Including the Administering of Medicines and First Aid Status Current Approval Curriculum Committee Maintenance Resources Responsibility
More informationImproving compliance with oral methotrexate guidelines. Action for the NHS
Patient safety alert 13 Alert Immediate action Action Update Information request Ref: NPSA/2006/13 Improving compliance with oral methotrexate guidelines Oral methotrexate is a safe and effective medication
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE. Patient s first names
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria: Cautions/Need for
More informationNOTE: Massive Transfusion Protocol (MTP) go to Appendix 17 and 17a for nursing guidelines and algorithm.
NURSING PROCEDURE TITLE: BLOOD PRODUCTS ADMINISTRATION Crossmatched & Uncrossmatched Products: Packed red blood cells, platelets, plasma, cryoprecipitate (homologous, autologous & directed donor) A. Prior
More informationProtocol for the Self Administration of Medication within the Locked Rehabilitation and Recovery Inpatient Unit
Protocol for the Self Administration of Medication within the Locked Rehabilitation and Recovery Inpatient Unit DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Assurance Sub Group Date ratified: 28
More informationRESEARCH GOVERNANCE POLICY
RESEARCH GOVERNANCE POLICY DOCUMENT CONTROL: Version: V6 Ratified by: Performance and Assurance Group Date ratified: 12 November 2015 Name of originator/author: Assistant Director of Research Name of responsible
More informationSOP Venesection Registered Nurses
HAEM / ONC WARD & DAY UNIT STANDARD OPERATING PROCEDURE SOP Venesection Registered Nurses Document Code Version Number 1 Issue Number 1 Date of Issue 07/03/2014 Review Interval 2 years Author (original
More informationLaundry Policy. DOCUMENT CONTROL: Version: 8 Quality Assurance Sub Committee Date ratified: 30 October 2017 Name of
Laundry Policy DOCUMENT CONTROL: Version: 8 Ratified by: Quality Assurance Sub Committee Date ratified: 30 October 2017 Name of Head of Facilities originator/author: Name of responsible Estates Sub Committee
More informationNursing Guidelines on the Administration of Coagulation Factor Concentrate
Nursing Guidelines on the Administration of Coagulation Factor Concentrate Version Number 2 Date of Issue 2 nd April 2014 Reference Number Review Interval Approved By Name: Fionnuala O Neill Title: Chairperson
More informationLevel 2 Award in Healthcare and Social Care Support Skills
Level 2 Award in Healthcare and Social Care Support Skills Qualification Specification ProQual 2015 Contents Page Introduction 3 The Qualifications and Credit Framework (QCF) 3 Qualification profile 4
More informationPatient Group Direction for ACICLOVIR (Version 02) Valid From 1 October September 2019
Version Control This PGD has been agreed by the following organisations FCMS PDS Medical Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history
More informationDerby Hospitals NHS Foundation Trust. Drug Assessment
Drug Assessment for Preparation and Administration of Oral, Enteral, Ophthalmic, Topical, PR, PV, Inhaled, Subcutaneous and Intramuscular Medicines to Patients (N.B. The preparation and administration
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE CONTINUOUS INFUSION
Patient identifier/label: Page 1 of 6 CYTARABINE Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital
More informationConsultation Group: See relevant page in the PGD. Review Date: October 2016
Patient Group Direction For The Administration Of Adrenaline (Epinephrine) By Trained Nurses In The Management Of Cardiac Arrest In The Medical High Dependency Unit/Coronary Care Unit (MHDU/CCU) Working
More informationNATIONAL PATIENT SAFETY AGENCY DRAFT PATIENT SAFETY ALERT. Safer Use of Injectable Medicines In Near-Patient Areas
NATIONAL PATIENT SAFETY AGENCY DRAFT PATIENT SAFETY ALERT Safer Use of Injectable Medicines In Near-Patient Areas Wide Stake Holder Consultation January March 2006 The NPSA is undertaking a wide stake
More informationPolicy. Blood Transfusion. Version: 6
Blood Transfusion Policy Reference No: P_CS_11 Version: 6 Ratified by: LCHS Trust Board Date ratified: 12 th September 2017 Name of originator/author: Diane Smith Name of responsible committee/individual:
More informationCOMPETENCIES FOR HEALTHCARE ASSISTANT IN SEXUAL HEALTH (BAND 3)
COMPETENCIES FOR HEALTHCARE ASSISTANT IN SEXUAL HEALTH (BAND 3) Dimension Level Indicators Areas of application to nursing practice Achieved - Signature and Date 1. Communication Level 2 Communicate with
More informationPGD5417. Clinical Performance Director of Nursing Allison Bussey
PGD5417 Patient Group Direction Administration of Adrenaline (Epinephrine) 1:1000 (1mg/ml) Injection By Registered Nurses and Midwives employed by South Staffordshire & Shropshire Healthcare Foundation
More informationHull Collaborative Academy Trust. Medical Policy
Medical Policy Dated issued: June 2018 Ratified by the Trust Board: Review Date: June 2019 1 Other related academy policies that support this Medical policy include: Attendance, Asthma, Child Protection,
More informationBLOOD TRANSFUSION PROCEDURES
BLOOD TRANSFUSION PROCEDURES October 2013 Review date: September 2015 Issue number: 5 Issued by: Hospital Transfusion Committee NHS SHETLAND CONTENTS Page 1 Statement on Transfusion Procedures 1 2 Consent
More informationAdvance Statements and Advance Decisions to Refuse Treatment Policy
Advance Statements and Advance Decisions to Refuse Treatment Policy DOCUMENT CONTROL: Version: V4 Ratified by: Mental Health Legislation Sub Committee Date ratified: 22 December 2017 Name of originator/author:
More informationMedicine Protocol for the Administration of HPV vaccine (Gardasil) by registered nurses and registered midwives
Medicine Protocol for the Administration of HPV vaccine (Gardasil) by registered nurses and registered midwives This medicine protocol is a specific written instruction for the administration of Gardasil,
More informationAdministration and Storage of Medication Policy
Name of School Corbets Tey School Policy Adopted 01/12/11 Next Review 01/12/12 Reviewed by Governors Name: Governors Signature: Administration and Storage of Medication Policy 1. The Board of Governors
More informationPolicy for Anticipatory Prescribing and Just in Case Bags
Policy for Anticipatory Prescribing and Just in Case Bags This policy was developed by Milton Keynes End of Life Care Medicine Group and has been adopted by all partner organisations (MK Clinical Commissioning
More informationHealth Authority Abu Dhabi
Health Authority Abu Dhabi Document Title: HAAD Standards for administration of medication in schools Document Ref. Number: HAAD/AMDS/SD/1.0 Version 1.0 Approval Date: 13 August 2012 Effective Date: August
More informationPolicy Checklist. Working Group: Administration of Infusion of Intravenous Fluids & Medicines in Neonates (Chairperson: Dr Hogan) YES
Policy Checklist Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Does this meet criteria of a Policy? Staff side consultation? Policy for the administration
More informationIntra-operative Cell Salvage. Competency Assessment Workbook. Trainee: Hospital: Trainer/Supervisor: Date Commenced: Date Completed:
Intra-operative Cell Salvage Competency Assessment Workbook Trainee: Hospital: Trainer/Supervisor: Commenced: Completed: Contents Introduction 1-2 Record of Assessors 4 Confirmation of Required Pre-assessment
More informationPatient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM IMATINIB. Patient s first names.
Patient identifier/label: Page 1 of 5 Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital NHS number
More informationUse of Intravenous devices for administration of fluid therapy in Neonates
This is an official Northern Trust policy and should not be edited in any way Use of Intravenous devices for administration of fluid therapy in Neonates Reference Number: NHSCT/12/534 Target audience:
More informationSystemic anti-cancer therapy Care Pathway
Network Guidance Document Status: Expiry Date: Version Number: Publication Date: Final July 2013 V2 July 2011 Page 1 of 9 Contents Contents... 2 STANDARDS FOR PREPARATION AND PHARMACY... 3 1.1 Facilities
More informationTransfusion of Blood Components and Products
Approved by: Vice President & Chief Medical Officer; and Vice President & Chief Operating Officer Transfusion of Blood Components and Products Corporate Policy & Procedures Manual Number: VII-B-395 Date
More information